Clinical Trial Update: Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the analgesic efficacy and safety of V116517 in adults with moderate to severe pain due to postherpetic neuralgia; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• V116517

Snippet

Sponsor: Purdue Pharma LP | Conditions: Postherpetic Neuralgia, Pain | Phase 2 | Status: COMPLETED